Vicarious Surgical (RBOT) Cash & Equivalents (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Cash & Equivalents of $7.8 million for Q4 2025, down 80.49% year-over-year from $40.1 million in Q4 2024, and down 41.73% quarter-over-quarter from $13.4 million in Q3 2025.
Vicarious Surgical (RBOT) Cash & Equivalents (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Cash & Equivalents for 6 consecutive years, with $7.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Equivalents fell 80.49% year-over-year to $7.8 million; the TTM figure through Dec 2025 stood at $7.8 million (down 80.49% YoY), while the FY2025 annual figure was $7.8 million, down 80.49% from the prior year.
- Cash & Equivalents declined to $7.8 million in Q4 2025 per RBOT's latest filing, from $13.4 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $185.0 million in Q3 2021 and bottomed at $1.0 million in Q1 2021.
- Historically, Cash & Equivalents has averaged $72.7 million across 5 years, with a median of $57.5 million in 2023.
- Annual changes were most pronounced in 2022 — Cash & Equivalents surged 15173.98% — and 2025, when it slumped 80.49%.
- Vicarious Surgical's Cash & Equivalents stood at $173.5 million in 2021, then sank by 33.02% to $116.2 million in 2022, then tumbled by 33.87% to $76.8 million in 2023, then plunged by 47.86% to $40.1 million in 2024, then plunged by 80.49% to $7.8 million in 2025.
- Business Quant data shows RBOT's Cash & Equivalents at $7.8 million in Q4 2025, $13.4 million in Q3 2025, and $24.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | 7.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.82 Mn |
| Sep 30, 2025 | 13.41 Mn |
| Jun 30, 2025 | 23.96 Mn |
| Mar 31, 2025 | 37.36 Mn |
| Dec 31, 2024 | 40.07 Mn |
| Sep 30, 2024 | 60.86 Mn |
| Jun 30, 2024 | 20.25 Mn |
| Mar 31, 2024 | 84.13 Mn |
| Dec 31, 2023 | 76.84 Mn |
| Sep 30, 2023 | 75.80 Mn |
| Jun 30, 2023 | 49.98 Mn |
| Mar 31, 2023 | 54.08 Mn |
| Dec 31, 2022 | 116.21 Mn |
| Sep 30, 2022 | 126.80 Mn |
| Jun 30, 2022 | 141.32 Mn |
| Mar 31, 2022 | 157.01 Mn |
| Dec 31, 2021 | 173.51 Mn |
| Sep 30, 2021 | 185.05 Mn |
| Jun 30, 2021 | 7.71 Mn |
| Mar 31, 2021 | 1.03 Mn |